Northpond Ventures — Full Portfolio

Vizgen develops high-throughput spatial profiling technologies, including MERFISH-based spatial genomics and spatial proteomics tools for life science research and precision oncology.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, US

George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inXiaowei Zhuang(Founder; Professor, Harvard University)inFenel Eloi(Director)Robert Carson(Executive Officer, Director)Rob Carson(Chief Executive Officer)in

Board seatSharon Kedar· per SEC Form D

Co-investorsARCH Venture Partners6 Dimensions CapitalApplied VenturesKilonova CapitalPura Vida InvestmentsRazor's Edge Ventures+2 more

Inflammatix develops host-response-based molecular diagnostics tests to identify acute infections and sepsis in emergency and critical care settings.

AI & Machine LearningBiotechHealthtechMedical DevicesBurlingame, US

Tim Sweeney(Co-Founder and CEO)Purvesh Khatri(Co-Founder and Chief Scientist)JONATHAN ROMANOWSKY(Executive Officer)

BoardKENNETH BAHK(Director)MICHAEL RUBIN(Director)DAVID PERSING(Director)

Co-investorsKhosla VenturesOSF VenturesDFJ

Mestag Therapeutics is an immunology company developing first-in-class agonist antibody therapies for cancer and inflammatory diseases based on fibroblast biology, and operates a RAFT platform for discovering new drug targets.

AI & Machine LearningBiotechHealthtech

Susan Hill(Founder & Chief Executive Officer)Michael B. Brenner(Founder)Chris Buckley(Founder)Mark Coles(Founder)Soumya Raychaudhuri(Founder)David A. Tuveson(Founder)

Co-investorsGV (Google Ventures)ForbionJohnson & Johnson Innovation – JJDCSV Health Investors

Octave develops blood-based biomarker tests for neurodegenerative diseases including multiple sclerosis, Parkinson's disease, and Alzheimer's disease.

AI & Machine LearningBiotechDigital HealthMedical DevicesMenlo Park, US

William Hagstrom(Founder and Chairman)Doug Biehn(President and CEO)

Co-investorsSandbox IndustriesSection 32Blue Venture FundsEcho Health VenturesHikma VenturesGreycroft+1 more

Transition Bio applies methods from physics, chemistry, biology, and machine learning to study protein biophysics—including protein aggregation, self-assembly, and protein-protein interactions—for developing therapeutics targeting health and disease.

AI & Machine LearningBiotechDeep TechCambridge, US

Tuomas Knowles(Executive Director, Co-Founder & Chief Technology Officer)Samuel Cohen(Executive Director & Co-Founder)G. Kelly Martin(Executive Chairman & Co-Founder)George Martin(Executive Officer, Director)Stephanie Torruella(Executive Officer)Preet Makkar(Executive Officer)

Co-investorsLifeforce CapitalMagnetic VenturesTaiho Ventures, LLCDolby Family Ventures

VitalBio develops the VitalOne, a diagnostic device that delivers comprehensive lab-grade blood test results in minutes from a small blood sample, using robotics, biochemistry, computer vision, and microfluidics.

BiotechDigital HealthMedical Devices

Vasu Nadella(Founder)in

Co-investorsNext VenturesInovia CapitalLachy GroomMarc BenioffSam Altman1955 Capital+6 more

Vizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples.

AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US

George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inRobert Carson(Executive Officer, Director)Terry Lo(Director)Seth Benson(Executive Officer)Simona Levi(Executive Officer)

Co-investorsARCH Venture PartnersM VenturesNovalis LifeSciences

Boston, US

Board seatSharon Kedar· per SEC Form D · $20M raise · filed Mar 2020

En Plus One Bio develops synthesis and manufacturing technology for RNA therapeutics, focused on producing high-purity long RNA with higher cycle efficiencies and novel chemical modifications.

BiotechDeep TechWatertown, US

Daniel Ahlstedt(Executive Officer, Director)Jonathan Rittichier(Founder)in

BoardAndrew Lee(Director)inSteven Kasok(Director)

Board seatPaxton Major· per SEC Form D

Co-investorsBreakout VenturesCoatue Management

BiotechNew Haven, US

Rong Fan(Director)Sean McKay(Executive Officer, Director)Sean Mackay(Executive Officer, Director)

BoardDaniel Wagner(Director)John Conley(Director)Gregory Ho(Director)

Board seatSharon Kedar· per SEC Form D · $85M raise · filed Jan 2021

Cambridge, US

Clinton Hansen(Executive Officer, Promoter)Wesley Wong(Executive Officer, Director, Promoter)

Board seatSteve LiapisElias Quijano· per SEC Form D · $15M raise · filed Sep 2025

Aro is a Brazilian technology platform that connects users with over 40 regulated credit partners to find personal loans, payroll (consignado CLT) loans, phone-collateral loans, and credit for people with negative credit records.

AI & Machine LearningB2B MarketplacesFintech

Co-investorsNorte Ventures17SigmaCowen Healthcare InvestmentsOnevc Venture Partners Llc

ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.

AI & Machine LearningBiotechHealthtechMedical DevicesCarlsbad, US

Paul Flook(Executive Officer, Director)Gregory J. Gosch(Executive Officer, Director)Lynne Rollins(Executive Officer)Aditya Rajagopal(Director)Axel Scherer(Director)

BoardJustin Klein(Director)in

Co-investorsAdjuvant CapitalGlobal BrainMoore Venture PartnersNew Enterprise Associates (NEA)Windham Capital PartnersDomain Associates+2 more

Culture Biosciences provides software and bioreactor hardware solutions for bioprocess development, enabling researchers to design, monitor, and analyze experiments remotely with cloud-native analytics and AI/ML insights.

AI & Machine LearningBiotechCloud ComputingHealthtechSan Francisco, US

Will Patrick(Founder/CEO)inMatt Ball(Founder/CTO)in

Co-investorsCompoundDCVC (Data Collective)GRIDS CapitalHemisphere Ventures LLCThe E14 FundY Combinator+4 more

Eleanor Health is an outpatient addiction treatment program that delivers remote evidence-based care for substance use disorder, including medication-assisted treatment and counseling.

Digital HealthHealthtechMental HealthWaltham, US

Dr. Nzinga Harrison(Chief Medical Officer and Co-founder)Corbin Petro(Executive Officer, Director)Srishti Mirchandani(Executive Officer)

BoardDavid Whelan(Director)inSonny Goyal(Director)Kurt Sheline(Director)in

Co-investorsEcho Health VenturesRethink ImpactGeneral CatalystTown Hall VenturesWarburg Pincus

Elephas develops elive, a live-tissue platform technology that predicts immunotherapy response in cancer patients by measuring real-time immune activity in intact tumor tissue.

BiotechDigital HealthHealthtechMedical DevicesMadison, US

Jonathan Oliner(Executive Officer)inManeesh K. Arora(Executive Officer, Director, Promoter)Maneesh Arora(Founder)inMichelle B. Arora(Director)Terrence P. Brady(Executive Officer)

Co-investorsARCH Venture PartnersSands Capital Ventures

San Diego protein-sequencing company behind the ProteoCode platform; ceased operations in late 2025.

Co-investorsARCH Venture PartnersDecheng CapitalAlexandriaDeerfield Management CompanyGV (Google Ventures)Nan Fung Life Sciences

BiotechPortola Valley, US

Lena Wu(Executive Officer, Director)Erik Gentalen(Director)Michael Rubin(Director)

BoardJenny Rooke(Director)in

Co-investorsVertical Venture PartnersGenoa Ventures

Kytopen develops non-viral gene delivery technology called Flowfect that combines fluid flow with electric fields to deliver payloads such as mRNA, DNA, and CRISPR Cas9 RNP into cells for high-throughput transfection.

BiotechDeep TechHardwareCambridge, US

Cullen Buie(Director)Paulo Garcia(Executive Officer, Director, Promoter)Michael Chiu(Director, Executive Officer)

BoardPaxton Major(Director)Ann DeWitt(Director)inPaul Wotton(Director)

Co-investorsBantam GroupHorizons VenturesMassVenturesSelvedge VentureTBD AngelsTelegraph Hill Partners+1 more

Outcomes4Me is an AI-driven patient platform that integrates with NCCN clinical oncology guidelines to provide personalized cancer care guidance, treatment options, clinical trial recommendations, and genetic testing information.

AI & Machine LearningDigital HealthHealthtechCambridge, US

Maya R. Said(Founder and CEO)Osama Rahma(Founder)

BoardAndrea Jackson(Director)inDavid Fleshman(Director)David Auckland(Director)

Co-investorsAsset Management CompanyHealthX VenturesSierra Ventures

Scitara provides cloud-based integration and data management software for scientific laboratories, enabling connection of lab instruments and applications into a unified environment with AI-powered analytics.

AI & Machine LearningBiotechData & InfrastructureSaaSMarlborough, US

Ajit Nagral(CEO & Chairman)Geoff Gerhardt(Executive Officer, Promoter)Vinayak Purohit(Executive Officer)

BoardCharles M. Hazard, Jr.(Director)Andrea Jackson(Director)inRohit Khanna(Director)

Co-investorsFlybridge Capital Partners

Slingshot Biosciences makes synthetic cell mimics used as standardized reference controls for flow cytometry and cell-based assays.

Emeryville, US

Jeffrey Kim(Executive Officer, Director)Jeff Kim(Founder)inAdam Wieschhaus(Director)Ronald J. Silberman(Director)

BoardCorey Ritter(Director)in

Co-investorsARCH Venture PartnersAnterra Capital

AgTechEmeryville, US

Eric Davidson(Director)Travis Bayer(Director)Paul Beck(Executive Officer)Dave Vosburg(Executive Officer)Adam Litle(Executive Officer, Director)Derek Norman(Director)

Co-investorsCavallo VenturesCultivian Sandbox VenturesS2G InvestmentsFall Line CapitalFootPrint CoalitionLeaps by Bayer+2 more

Uptime Health provides operational tools and preventive maintenance plans to healthcare practices to reduce downtime and ensure regulatory compliance.

Enterprise SoftwareHealthtechSaaSBoston, US

William Olsen(Executive Officer, Director)Jinesh Patel(Executive Officer, Director)in

BoardJohn Huysmans(Director)

Co-investorsBantam GroupC2 VenturesCaduceus Capital PartnersDIAKluz VenturesOverline+5 more